Skip to main content

Mɔkpɔkpɔ yeye na no me dɔdzẽ: Mina míasrɔ̃ nu tso PI3K Inhibitors ŋu le mɔ bɔbɔe aɖe nu (PI3K Inhibitors for ER+ Breast Cancer)

Mɔkpɔkpɔ yeye na no me dɔdzẽ: Mina míasrɔ̃ nu tso PI3K Inhibitors ŋu le mɔ bɔbɔe aɖe nu (PI3K Inhibitors for ER+ Breast Cancer)

Ne míese nya si nye no me dɔdzẽ la, vɔvɔ̃ ɖoa mía dometɔ geɖe. Gake nu vevitɔ kekeake si gɔme wòle be míase enye be menye no me dɔdzẽwo katãe sɔ o. Woƒe ƒomevi vovovowoe li. Wo dometɔ ɖekae nye ‘estrogen receptor positive’ alo abe alesi míeyɔnae le atikewɔwɔ me ene la , ER+ (Estrogen-Receptor-Positive) no me dɔdzẽ . Le nyateƒe me la, no me dɔdzẽ siwo wokpɔ la ƒe 80% koe nye esia ƒomevi. Eyata egbea míele nu ƒom tso atike yeye aɖe si kpɔ dzidzedze si ŋu woke ɖo be woatsɔ ada ER+ no me dɔdzẽ siawo ŋu.

Gbã la, mina míakpɔe ɖa be, nukae nye ER+ no me dɔdzẽ?

Ne míagblɔe kpuie la, lãmetsi si nye estrogen si le míaƒe ŋutilã me kpena ɖe kansa lãmenugbagbevi siawo ŋu wotsina. Tsɔe be ‘nulénu’ (nuxɔlawo) tɔxɛwo le kansa lãmenugbagbevi siawo ŋu le woƒe gowo dzi si estrogen lãmetsiŋusẽa ate ŋu abla ɖe wo ŋu. Ne ‘safui’ si woyɔna be estrogen hormone ge ɖe ‘gaƒoɖokui’ sia me la, kansa lãmenugbagbeviwo xɔa ‘dzesi’ be woama ahatsi.

Esia tae ɖɔktawo tsɔa lãmetsiŋusẽtike daa ER+ kansa zi geɖe ɖo . Dɔdamɔnu siawo wɔa dɔ to mɔxexe ɖe ‘safui’ (estrogen) nu be wòagabla ɖe ‘gaƒoɖokui’ (nuxɔlawo) ŋu o. Gake ɣeaɖewoɣi, vevietɔ ne kansa la kaka ɖe ŋutilã bliboa me (si de ŋgɔ alo kaka ɖe teƒe bubuwo) la, kansa lãmenugbagbevi siawo va zua ayetɔ ŋutɔ. Wova nɔa te ɖe lãmetsiŋusẽtike siawo nu, si fia be womewɔa nu ɖe ​​atikewɔwɔ ŋu nyuie o. Esiae nye ɣeyiɣi si me míehiã atikewɔmɔnu yeye siwo wɔa dɔ nyuie wu.

Kansa lãmenugbagbeviwo ƒe ‘tsitsi ƒe tɔtrɔ’ - PI3K kple PIK3CA domenyiŋusẽfianuwo

Esi ɖɔktawo kple dzɔdzɔmeŋutinunyalawo nɔ nusiwo gbɔ kansa siawo siwo te ŋu nɔa te ɖe lãmetsiŋusẽ nu tsona dim la, wokpɔ nu tɔxɛ aɖe: gbɔdzɔgbɔdzɔ aɖe le PI3K (Phosphatidylinositol-3-Kinase) mɔ , si nye dzesiɖoɖo vevi aɖe si kpɔa lãmenugbagbeviwo ƒe tsitsi, mama, kple agbenɔnɔ dzi le míaƒe ŋutilã me.

Bu PI3K mɔ sia be enye ‘switchboard’ gã aɖe le lãmenugbagbevi aɖe me. Ekpɔa ŋusẽ ɖe nyametsotso siwo wowɔna le nenye be ele be lãmenugbagbevi aɖe natsi alo amae ŋu. Domenyiŋusẽfianu vevi siwo kpɔa ŋusẽ ɖe switchboard sia dzi dometɔ ɖekae nye PIK3CA domenyiŋusẽfianu .

Le kansadɔnɔ aɖewo gome la, domenyiŋusẽfianu sia ƒe tɔtrɔ le PIK3CA ŋu , si fia be tɔtrɔ alo nusi gblẽ. Ele abe ‘tsitsi’ ƒe ʋuƒo si le switchboard la dzi la tsi eye ‘wòaʋu’ ɣesiaɣi ene. Emegbe lãmenugbagbeviawo dzea mama gɔme henɔa tsitsim le mɔ si dzi womate ŋu aɖu o nu. Esia koŋue hea kansa vɛ. Numekukuwo ɖee fia be PIK3CA domenyiŋusẽfianu ƒe tɔtrɔ sia le dɔnɔ siwo ŋu ER+ no me dɔdzẽ le ƒe 40% lɔƒo.

Eyata nukae nye PI3K Mɔxenu siawo?

Le afisia, abe kuxi sia gbɔ kpɔnu ene la, wole atikewo ƒe hatsotso aɖe si woyɔna be PI3K mɔxenuwo tom vɛ. Nu bɔbɔetɔ kekeake si atike siawo wɔna enye be woɖea ‘tsitsi ƒe tɔtrɔ’ (PI3K mɔ) si megblɔ va yi si tsi ‘dzi’ la ɖa nyuie.

Kpuie ko la, atike siawo le abe elektrikdɔwɔla bibi aɖe ene. Egena ɖe eme eye wòɖɔa ʋuƒo ma si ƒe ʋuʋudedi le kpuie la ɖo, si wɔnɛ be elektrikŋusẽ si mehiã o la tɔa te. Le mɔ ma ke nu la, PI3K Inhibitors tɔa te tsitsi ƒe dzesi si mehiã o si yia kansa lãmenugbagbeviwo gbɔ, si wɔnɛ be kansa lãmenugbagbeviwo kuna eye wokpena ɖe dɔdzẽwo ŋu be woaɖe wo dzi akpɔtɔ.

Zi geɖe la, esiawo va le atike siwo woano me. Zi geɖe la, wonaa atike sia dɔnɔwo tsɔ kpena ɖe lãmetsiŋusẽtike (estrogen blocker) si míeyɔ va yi ŋu.

Aleke mawɔ anya ne atikewɔwɔ sia sɔ nam?

Esia nye nyabiase vevi aɖe ŋutɔ. Wometsɔa PI3K Mɔxenu naa no me dɔdzẽ dɔnɔwo katã o. Wotrɔ asi le wo ŋu koŋ be:

  • Le nyɔnu siwo tsi megbe kple ŋutsu dɔnɔwo gome.
  • Ele be kansa la nanye HR+ (Hormone-Receptor-Positive) kple HER2-Negative .
  • Nu vevitɔ kekeake: Ele be domenyiŋusẽfianu ƒe tɔtrɔ si nye PIK3CA nanɔ kansa lãmenugbagbeviwo si .

Be nànya ne domenyiŋusẽfianu ƒe tɔtrɔ sia le wò kansa ŋu la, wò ɖɔkta awɔ dodokpɔ tɔxɛ aɖe. Zi geɖe la, esia lɔa ʋu alo lãkusi sue aɖe (biopsy) si woɖe tso dɔdzẽa me ɖe eme. Dodokpɔ ma me tsonu aɖee afia nenye be atikewɔwɔ sia sɔ na wò.

Dzedze na atikewɔwɔ Nuɖᴐɖᴐ
Kansa ƒomevi Ele be wòanye no me dɔdzẽ si de ŋgɔ si nye HR+ (hormone receptor positive) kple HER2- (HER2 negative) ƒomevi.
Domenyiŋusẽfianu ƒe tɔtrɔEle be PIK3CA domenyiŋusẽfianu ƒe tɔtrɔ nanɔ anyi. Dodokpɔ tɔxɛ aɖe ɖo kpe esia dzi.
Dzigbɔɖi Zi geɖe la, wokafunɛ na nyɔnu siwo tsi megbe kple ŋutsu dɔnɔwo.

Nu gbegblẽ kawoe atike siawo ate ŋu ahe vɛ?

Abe kansadɔdamɔnu ɖesiaɖe ene la, PI3K mɔxenuwo ate ŋu ahe nugbegblẽ aɖewo vɛ. Ke hã, nusiawo medzɔna le ame sia ame dzi le mɔ ɖeka nu o. Azɔ hã, mɔ aɖewo li fifia siwo dzi woato akpɔ nugbegblẽ le ame ŋu siawo gbɔ.

Nusiwo wògblẽna le ame ŋu siwo bɔ wu dometɔ aɖewoe nye:

  • Aɖuɖɔtoe kple ʋuʋudedi
  • Nuɖuɖudzroame ƒe vɔvɔ kple lolo dzi ɖeɖe kpɔtɔ
  • Nu me ƒe abiwo
  • Taɖa ƒe ŋeŋe
  • Ŋusẽ ɖesiaɖe si wòakpɔ ɖe ayiku, aklã, alo dɔgbo ƒe dɔwɔwɔ dzi
  • Ŋutilã me ʋuʋudedi, si nu sẽna ɣeaɖewoɣi, ate ŋu adzɔ, si ana ŋutigbalẽa naɖe alo avuvu.
  • Sukli si sɔ gbɔ ɖe ʋu me: Esia nye atike ƒe hatsotso sia koŋ ƒe nugbegblẽ le ame ŋu si bɔ, elabena PI3K mɔa kpɔa gome le sukli ƒe asitɔtrɔ le míaƒe ŋutilã me me.

Mègana nugbegblẽ le ame ŋu siawo navɔ̃ o. Wò ɖɔkta alé ŋku ɖe ŋuwò edziedzi be esiawo le asiwò hã. Ne ehiã la, aɖe atikeawo ƒe agbɔsɔsɔ dzi akpɔtɔ, adzudzɔ enono hena ɣeyiɣi aɖe (atikewo ƒe mɔkeke), alo ana atike bubu wò be nàtsɔ aɖu eƒe nugbegblẽ le ame ŋu dzi. Mègadzudzɔ wò atikewo nono alo atrɔ atikeawo ƒe agbɔsɔsɔme gbeɖe ne mèbia wò ɖɔkta o.

Numekukuwo ɖee fia be suklidɔtike nono be woatsɔ akpɔ sukli ƒe agbɔsɔsɔ le ʋu me dzi alo nuɖuɖu si me carb mesɔ gbɔ ɖo o, si me ami sɔ gbɔ ɖo ( ketogenic diet ) dzi wɔwɔ ate ŋu ana atike sia nawɔ dɔ nyuie wu. Gake ele vevie be nàƒo nu kple wò ɖɔkta hafi awɔ tɔtrɔ ɖesiaɖe le nuɖuɖu ŋu.

Ðe atikewɔwɔ sia wɔa dɔ ŋutɔŋutɔa?

Ɛ̃. Esiae nye nu vevitɔ kekeake. Dɔdamɔnu dodokpɔ geɖe ɖee fia be dɔnɔ siwo ŋu no me dɔdzẽ si nye ER+ si me PIK3CA ƒe tɔtrɔ le ate ŋu akpɔ viɖe tso PI3K mɔxenu si wotsɔ kpe ɖe lãmetsiŋusẽtike ŋu.

Numekuku gã aɖe ɖee fia be dɔnɔ siwo xɔ atike sia si wotsɔ tsakae la nɔa agbe abe ɣleti 11 ene eye womekpɔa ŋgɔyiyi o . Esia mede ɣleti 6 na dɔnɔ siwo ƒe domenyiŋusẽfianu ƒe tɔtrɔ ɖeka ma ke siwo mexɔ PI3K mɔxenu o. Esia nye tɔtrɔ gã aɖe kple mɔkpɔkpɔ gã aɖe. Le dzidzedzekpɔkpɔ sia ta la, wole atike yeye siwo le atikewo ƒe hatsotso sia me wɔm fifia.

Gbedasi si Wotsɔ Yi Aƒeme

  • Menye no me dɔdzẽwo katãe sɔ o. Wò kansa ƒomevi tɔxɛ (e.g. ER+, HER2-, PIK3CA ƒe tɔtrɔ) nyanya le vevie be nàtia atike si sɔ wu eye wòwɔa dɔ nyuie wu.
  • PI3K Inhibitors nye egbegbe atike si woɖo ɖe no me dɔdzẽ si me ER+ kple PIK3CA domenyiŋusẽfianu ƒe tɔtrɔ le.
  • Menye amesiamee dɔdamɔnu sia nye na o. Wò ɖɔkta akpɔe ɖa be esɔ na wò hã le dodokpɔ tɔxɛwo wɔwɔ vɔ megbe.
  • Atike siawo ate ŋu ahe nugbegblẽ le ame ŋu vɛ, vevietɔ sukli ƒe agbɔsɔsɔ si le ʋu me, gake wò ɖɔkta ate ŋu akpe ɖe ŋuwò nàɖu wo dzi ahakpɔ wo dzi.
  • Ne ènya nu tso wò atikewɔwɔ ƒe ɖoɖoa ŋu nyuie eye nèƒo nu kple wò ɖɔkta gaglãa la, ana ŋusẽ nanɔ ŋuwò eye nàɖu ɖokuiwò dzi le mɔzɔzɔ sia me. Mègatsi dzi o, egbegbe atikewɔwɔ le ŋgɔ yim gbesiagbe.

No me dɔdzẽ, kansa dada, PI3K mɔxenuwo, ER+ no me dɔdzẽ, PIK3CA domenyiŋusẽfianu, lãmetsiŋusẽtike, kansatikewo
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

Womeɖo nya aɖeke ɖe amewo haɖe o. Tsɔ wò nyaŋuɖoɖo kpe ɖe afisia zi gbãtɔ.

Tsɔ wò nyaŋuɖoɖo kpee

Taflatse bu akɔnta be: 9 + 9 =
Mɔkpɔkpɔ yeye na no me dɔdzẽ: Mina míasrɔ̃ nu tso PI3K Inhibitors ŋu le mɔ bɔbɔe aɖe nu (PI3K Inhibitors for ER+ Breast Cancer)
Atikewosiamlɔm 6 lia 2026

Mɔkpɔkpɔ yeye na no me dɔdzẽ: Mina míasrɔ̃ nu tso PI3K Inhibitors ŋu le mɔ bɔbɔe aɖe nu (PI3K Inhibitors for ER+ Breast Cancer)

Ne míese nya si nye no me dɔdzẽ la, vɔvɔ̃ ɖoa mía dometɔ geɖe. Gake nu vevitɔ kekeake si gɔme wòle be míase enye be menye no me dɔdzẽwo katãe sɔ o. Woƒe ƒomevi vovovowoe li. Wo dometɔ ɖekae nye ‘estrogen receptor positive’ alo abe alesi míeyɔnae le atikewɔwɔ me ene la , ER+ (Estrogen-Receptor-Positive) no me dɔdzẽ . Le nyateƒe me la, no me dɔdzẽ siwo wokpɔ la ƒe 80% koe nye esia ƒomevi. Eyata egbea míele nu ƒom tso atike yeye aɖe si kpɔ dzidzedze si ŋu woke ɖo be woatsɔ ada ER+ no me dɔdzẽ siawo ŋu.

Gbã la, mina míakpɔe ɖa be, nukae nye ER+ no me dɔdzẽ?

Ne míagblɔe kpuie la, lãmetsi si nye estrogen si le míaƒe ŋutilã me kpena ɖe kansa lãmenugbagbevi siawo ŋu wotsina. Tsɔe be ‘nulénu’ (nuxɔlawo) tɔxɛwo le kansa lãmenugbagbevi siawo ŋu le woƒe gowo dzi si estrogen lãmetsiŋusẽa ate ŋu abla ɖe wo ŋu. Ne ‘safui’ si woyɔna be estrogen hormone ge ɖe ‘gaƒoɖokui’ sia me la, kansa lãmenugbagbeviwo xɔa ‘dzesi’ be woama ahatsi.

Esia tae ɖɔktawo tsɔa lãmetsiŋusẽtike daa ER+ kansa zi geɖe ɖo . Dɔdamɔnu siawo wɔa dɔ to mɔxexe ɖe ‘safui’ (estrogen) nu be wòagabla ɖe ‘gaƒoɖokui’ (nuxɔlawo) ŋu o. Gake ɣeaɖewoɣi, vevietɔ ne kansa la kaka ɖe ŋutilã bliboa me (si de ŋgɔ alo kaka ɖe teƒe bubuwo) la, kansa lãmenugbagbevi siawo va zua ayetɔ ŋutɔ. Wova nɔa te ɖe lãmetsiŋusẽtike siawo nu, si fia be womewɔa nu ɖe ​​atikewɔwɔ ŋu nyuie o. Esiae nye ɣeyiɣi si me míehiã atikewɔmɔnu yeye siwo wɔa dɔ nyuie wu.

Kansa lãmenugbagbeviwo ƒe ‘tsitsi ƒe tɔtrɔ’ - PI3K kple PIK3CA domenyiŋusẽfianuwo

Esi ɖɔktawo kple dzɔdzɔmeŋutinunyalawo nɔ nusiwo gbɔ kansa siawo siwo te ŋu nɔa te ɖe lãmetsiŋusẽ nu tsona dim la, wokpɔ nu tɔxɛ aɖe: gbɔdzɔgbɔdzɔ aɖe le PI3K (Phosphatidylinositol-3-Kinase) mɔ , si nye dzesiɖoɖo vevi aɖe si kpɔa lãmenugbagbeviwo ƒe tsitsi, mama, kple agbenɔnɔ dzi le míaƒe ŋutilã me.

Bu PI3K mɔ sia be enye ‘switchboard’ gã aɖe le lãmenugbagbevi aɖe me. Ekpɔa ŋusẽ ɖe nyametsotso siwo wowɔna le nenye be ele be lãmenugbagbevi aɖe natsi alo amae ŋu. Domenyiŋusẽfianu vevi siwo kpɔa ŋusẽ ɖe switchboard sia dzi dometɔ ɖekae nye PIK3CA domenyiŋusẽfianu .

Le kansadɔnɔ aɖewo gome la, domenyiŋusẽfianu sia ƒe tɔtrɔ le PIK3CA ŋu , si fia be tɔtrɔ alo nusi gblẽ. Ele abe ‘tsitsi’ ƒe ʋuƒo si le switchboard la dzi la tsi eye ‘wòaʋu’ ɣesiaɣi ene. Emegbe lãmenugbagbeviawo dzea mama gɔme henɔa tsitsim le mɔ si dzi womate ŋu aɖu o nu. Esia koŋue hea kansa vɛ. Numekukuwo ɖee fia be PIK3CA domenyiŋusẽfianu ƒe tɔtrɔ sia le dɔnɔ siwo ŋu ER+ no me dɔdzẽ le ƒe 40% lɔƒo.

Eyata nukae nye PI3K Mɔxenu siawo?

Le afisia, abe kuxi sia gbɔ kpɔnu ene la, wole atikewo ƒe hatsotso aɖe si woyɔna be PI3K mɔxenuwo tom vɛ. Nu bɔbɔetɔ kekeake si atike siawo wɔna enye be woɖea ‘tsitsi ƒe tɔtrɔ’ (PI3K mɔ) si megblɔ va yi si tsi ‘dzi’ la ɖa nyuie.

Kpuie ko la, atike siawo le abe elektrikdɔwɔla bibi aɖe ene. Egena ɖe eme eye wòɖɔa ʋuƒo ma si ƒe ʋuʋudedi le kpuie la ɖo, si wɔnɛ be elektrikŋusẽ si mehiã o la tɔa te. Le mɔ ma ke nu la, PI3K Inhibitors tɔa te tsitsi ƒe dzesi si mehiã o si yia kansa lãmenugbagbeviwo gbɔ, si wɔnɛ be kansa lãmenugbagbeviwo kuna eye wokpena ɖe dɔdzẽwo ŋu be woaɖe wo dzi akpɔtɔ.

Zi geɖe la, esiawo va le atike siwo woano me. Zi geɖe la, wonaa atike sia dɔnɔwo tsɔ kpena ɖe lãmetsiŋusẽtike (estrogen blocker) si míeyɔ va yi ŋu.

Aleke mawɔ anya ne atikewɔwɔ sia sɔ nam?

Esia nye nyabiase vevi aɖe ŋutɔ. Wometsɔa PI3K Mɔxenu naa no me dɔdzẽ dɔnɔwo katã o. Wotrɔ asi le wo ŋu koŋ be:

  • Le nyɔnu siwo tsi megbe kple ŋutsu dɔnɔwo gome.
  • Ele be kansa la nanye HR+ (Hormone-Receptor-Positive) kple HER2-Negative .
  • Nu vevitɔ kekeake: Ele be domenyiŋusẽfianu ƒe tɔtrɔ si nye PIK3CA nanɔ kansa lãmenugbagbeviwo si .

Be nànya ne domenyiŋusẽfianu ƒe tɔtrɔ sia le wò kansa ŋu la, wò ɖɔkta awɔ dodokpɔ tɔxɛ aɖe. Zi geɖe la, esia lɔa ʋu alo lãkusi sue aɖe (biopsy) si woɖe tso dɔdzẽa me ɖe eme. Dodokpɔ ma me tsonu aɖee afia nenye be atikewɔwɔ sia sɔ na wò.

Dzedze na atikewɔwɔ Nuɖᴐɖᴐ
Kansa ƒomevi Ele be wòanye no me dɔdzẽ si de ŋgɔ si nye HR+ (hormone receptor positive) kple HER2- (HER2 negative) ƒomevi.
Domenyiŋusẽfianu ƒe tɔtrɔEle be PIK3CA domenyiŋusẽfianu ƒe tɔtrɔ nanɔ anyi. Dodokpɔ tɔxɛ aɖe ɖo kpe esia dzi.
Dzigbɔɖi Zi geɖe la, wokafunɛ na nyɔnu siwo tsi megbe kple ŋutsu dɔnɔwo.

Nu gbegblẽ kawoe atike siawo ate ŋu ahe vɛ?

Abe kansadɔdamɔnu ɖesiaɖe ene la, PI3K mɔxenuwo ate ŋu ahe nugbegblẽ aɖewo vɛ. Ke hã, nusiawo medzɔna le ame sia ame dzi le mɔ ɖeka nu o. Azɔ hã, mɔ aɖewo li fifia siwo dzi woato akpɔ nugbegblẽ le ame ŋu siawo gbɔ.

Nusiwo wògblẽna le ame ŋu siwo bɔ wu dometɔ aɖewoe nye:

  • Aɖuɖɔtoe kple ʋuʋudedi
  • Nuɖuɖudzroame ƒe vɔvɔ kple lolo dzi ɖeɖe kpɔtɔ
  • Nu me ƒe abiwo
  • Taɖa ƒe ŋeŋe
  • Ŋusẽ ɖesiaɖe si wòakpɔ ɖe ayiku, aklã, alo dɔgbo ƒe dɔwɔwɔ dzi
  • Ŋutilã me ʋuʋudedi, si nu sẽna ɣeaɖewoɣi, ate ŋu adzɔ, si ana ŋutigbalẽa naɖe alo avuvu.
  • Sukli si sɔ gbɔ ɖe ʋu me: Esia nye atike ƒe hatsotso sia koŋ ƒe nugbegblẽ le ame ŋu si bɔ, elabena PI3K mɔa kpɔa gome le sukli ƒe asitɔtrɔ le míaƒe ŋutilã me me.

Mègana nugbegblẽ le ame ŋu siawo navɔ̃ o. Wò ɖɔkta alé ŋku ɖe ŋuwò edziedzi be esiawo le asiwò hã. Ne ehiã la, aɖe atikeawo ƒe agbɔsɔsɔ dzi akpɔtɔ, adzudzɔ enono hena ɣeyiɣi aɖe (atikewo ƒe mɔkeke), alo ana atike bubu wò be nàtsɔ aɖu eƒe nugbegblẽ le ame ŋu dzi. Mègadzudzɔ wò atikewo nono alo atrɔ atikeawo ƒe agbɔsɔsɔme gbeɖe ne mèbia wò ɖɔkta o.

Numekukuwo ɖee fia be suklidɔtike nono be woatsɔ akpɔ sukli ƒe agbɔsɔsɔ le ʋu me dzi alo nuɖuɖu si me carb mesɔ gbɔ ɖo o, si me ami sɔ gbɔ ɖo ( ketogenic diet ) dzi wɔwɔ ate ŋu ana atike sia nawɔ dɔ nyuie wu. Gake ele vevie be nàƒo nu kple wò ɖɔkta hafi awɔ tɔtrɔ ɖesiaɖe le nuɖuɖu ŋu.

Ðe atikewɔwɔ sia wɔa dɔ ŋutɔŋutɔa?

Ɛ̃. Esiae nye nu vevitɔ kekeake. Dɔdamɔnu dodokpɔ geɖe ɖee fia be dɔnɔ siwo ŋu no me dɔdzẽ si nye ER+ si me PIK3CA ƒe tɔtrɔ le ate ŋu akpɔ viɖe tso PI3K mɔxenu si wotsɔ kpe ɖe lãmetsiŋusẽtike ŋu.

Numekuku gã aɖe ɖee fia be dɔnɔ siwo xɔ atike sia si wotsɔ tsakae la nɔa agbe abe ɣleti 11 ene eye womekpɔa ŋgɔyiyi o . Esia mede ɣleti 6 na dɔnɔ siwo ƒe domenyiŋusẽfianu ƒe tɔtrɔ ɖeka ma ke siwo mexɔ PI3K mɔxenu o. Esia nye tɔtrɔ gã aɖe kple mɔkpɔkpɔ gã aɖe. Le dzidzedzekpɔkpɔ sia ta la, wole atike yeye siwo le atikewo ƒe hatsotso sia me wɔm fifia.

Gbedasi si Wotsɔ Yi Aƒeme

  • Menye no me dɔdzẽwo katãe sɔ o. Wò kansa ƒomevi tɔxɛ (e.g. ER+, HER2-, PIK3CA ƒe tɔtrɔ) nyanya le vevie be nàtia atike si sɔ wu eye wòwɔa dɔ nyuie wu.
  • PI3K Inhibitors nye egbegbe atike si woɖo ɖe no me dɔdzẽ si me ER+ kple PIK3CA domenyiŋusẽfianu ƒe tɔtrɔ le.
  • Menye amesiamee dɔdamɔnu sia nye na o. Wò ɖɔkta akpɔe ɖa be esɔ na wò hã le dodokpɔ tɔxɛwo wɔwɔ vɔ megbe.
  • Atike siawo ate ŋu ahe nugbegblẽ le ame ŋu vɛ, vevietɔ sukli ƒe agbɔsɔsɔ si le ʋu me, gake wò ɖɔkta ate ŋu akpe ɖe ŋuwò nàɖu wo dzi ahakpɔ wo dzi.
  • Ne ènya nu tso wò atikewɔwɔ ƒe ɖoɖoa ŋu nyuie eye nèƒo nu kple wò ɖɔkta gaglãa la, ana ŋusẽ nanɔ ŋuwò eye nàɖu ɖokuiwò dzi le mɔzɔzɔ sia me. Mègatsi dzi o, egbegbe atikewɔwɔ le ŋgɔ yim gbesiagbe.

No me dɔdzẽ, kansa dada, PI3K mɔxenuwo, ER+ no me dɔdzẽ, PIK3CA domenyiŋusẽfianu, lãmetsiŋusẽtike, kansatikewo
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

Womeɖo nya aɖeke ɖe amewo haɖe o. Tsɔ wò nyaŋuɖoɖo kpe ɖe afisia zi gbãtɔ.

Tsɔ wò nyaŋuɖoɖo kpee

Taflatse bu akɔnta be: 9 + 9 =